液基细胞学检测联合P16/Ki67蛋白、血清SCCA和CA125检测对宫颈癌早期筛查的诊断价值(5)
[14] Porcari AM，Negrao F，Tripodi GL，et al. Molecular Signatures of High-Grade Cervical Lesions[J]. Frontiers in Oncology，2018，8：99.
[15] Escobar-Hoyos LF，Yang J，Zhu J，et al.Keratin 17 in premalignant and malignant squamous lesions of the cervix：proteomic discovery and immunohistochemical validation as a diagnostic and prognostic biomarker[J]. Modern Pathology，2014，27(4)：621-630.
[16] Chen Y，Xu J，Zhang R，et al. Assessment of data pre-processing methods for LC-MS/MS-based metabolomics of uterine cervix cancer[J]. The Analyst，2013，138(9)： 2669-2677.
[17] Mu AK，Lim BK，Aminudin N，et al. Application of SELDI-TOF in N-glycopeptides profiling of the urine from patients with endometrial，ovarian and cervical cancer[J]. Archives of Physiology and Biochemistry，2016，122(3)：111-116.
[18] Yin MZ，Tan S. Identification of phosphatidylcholine and lysophosphatidylcholine as novel biomarkers for cervical cancers in a prospective cohort study[J]. Tumour biology：the journal of the International Society for Oncodevelopmental Biology and Medicine，2016， 37(4)：5485-5492.
[19] Liu Y，Wei F，Wang F，et al.Serum peptidome profiling analysis for the identification of potential biomarkers in cervical intraepithelial neoplasia patients[J]. Biochemical and Biophysical Research Communications，2015，465(3)：476-480.
[20] Yang K，Xia B，Wang W，et al. A Comprehensive Analysis of Metabolomics and Transcriptomics in Cervical Cancer[J]. Scientific Reports，2017，7：43353.
(收稿日期：2019-04-17), 百拇医药(任莹 丛玲华 何喻 方来福)
[15] Escobar-Hoyos LF，Yang J，Zhu J，et al.Keratin 17 in premalignant and malignant squamous lesions of the cervix：proteomic discovery and immunohistochemical validation as a diagnostic and prognostic biomarker[J]. Modern Pathology，2014，27(4)：621-630.
[16] Chen Y，Xu J，Zhang R，et al. Assessment of data pre-processing methods for LC-MS/MS-based metabolomics of uterine cervix cancer[J]. The Analyst，2013，138(9)： 2669-2677.
[17] Mu AK，Lim BK，Aminudin N，et al. Application of SELDI-TOF in N-glycopeptides profiling of the urine from patients with endometrial，ovarian and cervical cancer[J]. Archives of Physiology and Biochemistry，2016，122(3)：111-116.
[18] Yin MZ，Tan S. Identification of phosphatidylcholine and lysophosphatidylcholine as novel biomarkers for cervical cancers in a prospective cohort study[J]. Tumour biology：the journal of the International Society for Oncodevelopmental Biology and Medicine，2016， 37(4)：5485-5492.
[19] Liu Y，Wei F，Wang F，et al.Serum peptidome profiling analysis for the identification of potential biomarkers in cervical intraepithelial neoplasia patients[J]. Biochemical and Biophysical Research Communications，2015，465(3)：476-480.
[20] Yang K，Xia B，Wang W，et al. A Comprehensive Analysis of Metabolomics and Transcriptomics in Cervical Cancer[J]. Scientific Reports，2017，7：43353.
(收稿日期：2019-04-17), 百拇医药(任莹 丛玲华 何喻 方来福)